PA
BKSY icon

PharVision Advisers’s BlackSky Technology BKSY Stock Holding History

PharVision Advisers’s Portfolio BKSY Stock Details BKSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,567
Closed -$386K – 160
2025
Q4 		$386K Buy
+20,567
New +$419K 0.2% 143

Other funds holding BKSY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
LA
LBP AM Paris, France $7.31B AUM 29.14% 1-Year Est. Return

PharVision Advisers's BKSY Position: Q1 2026 in Review

PharVision Advisers sold out of BlackSky Technology (BKSY) in Q1 2026, closing a stake of 20,567 shares — an estimated $386K sold.

PharVision Advisers first reported a position in BKSY in Q4 2025 and held it in 1 quarter. The position peaked at $386K in Q4 2025. 184 funds tracked by Wall St. Rank hold BKSY as of Q1 2026.

  • PharVision Advisers reported no remaining BlackSky Technology position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 20,567 BlackSky Technology shares in Q1 2026, an estimated $386K.
  • PharVision Advisers first reported a position in BlackSky Technology in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's BlackSky Technology position peaked at $386K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held BlackSky Technology as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.